Blood and Organ Banks
Industry Profile Report
Dive Deep into the industry with a 25+ page industry report (pdf format) including the following chapters
Industry Overview Current Conditions, Industry Structure, How Firms Operate, Industry Trends, Credit Underwriting & Risks, and Industry Forecast.
Call Preparation Call Prep Questions, Industry Terms, and Weblinks.
Financial Insights Working Capital, Capital Financing, Business Valuation, and Financial Benchmarks.
Industry Profile Excerpts
Industry Overview
The 1,500 blood and organ banks in the US collect, store, and distribute blood and blood products, organs, and tissues. Blood banks and organ banks are non-profit organizations. Tissue banks and plasma banks can operate as for-profit entities. Blood and organ banks may have contracts with hospitals, healthcare providers, pharmaceutical companies, or other organizations.
Extremely Perishable Inventory
Blood, organs, and tissue are extremely perishable and require specialized removal processes and storage conditions.
Limited Sources of Supply
Supply of blood, organs, and tissue is dependent on the availability of donors, which is well beyond the control of the industry.
Industry size & Structure
The average blood or organ bank employs 48-49 workers and generates $9 million in annual revenue.
- The blood and organ bank industry consists of 1,500 establishments that employ 76,800 workers and generate $14 billion annually.
- Non-profit organizations account for 52% of establishments and about 71% of revenue. For-profit organizations account for 48% of establishments and about 29% of revenue. Blood banks and organ banks are non-profit organizations. Tissue banks and plasma banks can operate as for-profit entities.
- The industry is concentrated; the top 50 companies account for over 84% of industry revenue.
- Large organizations include the American Red Cross, America's Blood Centers, and the Musculoskeletal Transplant Foundation. In the US, 58 non-profit organ procurement organizations (OPO) coordinate the organ donation process.
Industry Forecast
Blood and Organ Banks Industry Growth
Recent Developments
Mar 6, 2023 - Heart Reprogramming Could Be First Step Toward Heart Banking
- A drug approved to treat seizures, bipolar disorder, and prevent migraine headaches may improve heart transplant outcomes by increasing the time an organ can be preserved outside the body. Researchers at the University of Michigan have found that valproic acid flips a switch to produce a metabolite that could reduce stress on the heart during storage and transport. “If you switch that gene on, it will benefit the heart by really reducing all the oxidative stress,” said Dr. Paul Tang. “When you have a heart that’s getting stored, there are harmful metabolites that cause inflammation and oxidative stress and there’s more of it the longer the heart gets stored. By regulating this gene, we can really shut down and greatly reduce the accumulation of the effects of these harmful metabolites and also switches on anti-inflammatory and antioxidant proteins.”
- Gay and bisexual men in monogamous relationships will no longer be required to abstain from sex to donate blood under proposed federal guidelines announced in late January. The proposed relaxation of restrictions by the Food and Drug Administration follows years of pressure by blood banks, the American Medical Association and LGBT rights organizations. The new risk assessment would ask potential donors, regardless of gender and sexual orientation, if they have had any new sexual partners or multiple partners in the past three months. They can give blood if they say no. Those who have had new or multiple partners would be asked if they had engaged in anal intercourse in the past three months; those who have would be asked to wait three months to donate. The new guidelines blood donation guidelines would also bar women from giving blood for the first time if they had anal sex with a new partner or while having multiple partners, even though heterosexual anal intercourse has not been a major focus on public health efforts to contain HIV.
- Researchers are testing lab-grown blood in human study participants. The project, called RESTORE, is a collaboration between scientists from three universities in the United Kingdom, and from England’s National Health System Blood and Transplant. The goal is to supplement the natural blood supply with fabricated red blood cells, which are grown from human stem cells. RESTORE scientists obtain a standard pint-sized blood donation from a human donor to begin making the blood. They then use magnetic beads to separate about 500,000 stem cells out from the rest of the tissue. These stem cells are encouraged to multiply until they reach a population of about 50 billion, approximately 15 billion of which are considered to be at the appropriate stage of development for transplant. Researchers have transfused the lab-grown blood into two healthy recipients, each of whom received five to 10 milliliters (approximately one to two teaspoons).
- Maine’s Red Cross is seeking more racially diverse donors. Genetically inherited medical conditions such as sickle cell disease and thalassemia affect specific populations, and treatment can include frequent blood transfusions. The majority of people with sickle cell disease are of African descent. It is also more commonly found in people of Hispanic, Indian, Asian, or Middle Eastern ancestry. “The country is becoming more and more diverse, and we need to have a blood supply that’s diverse,” said Thomas Hinman, market manager for Northern New England Blood Services of American Red Cross. Experts say that the need for racially diverse blood donations isn’t just an issue in Maine. African Americans make up 13% of the US population but less than 3% of blood donors, according to the Red Cross.
Get A Demo
Vertical IQ’s Industry Intelligence Platform
See for yourself why over 60,000 users trust Vertical IQ for their industry research and call preparation needs. Our easy-to-digest industry insights save call preparation time and help differentiate you from the competition.
Build valuable, lasting relationships by having smarter conversations -
check out Vertical IQ today.